" /> incretin mimetics and incretin enhancers - CISMeF





Preferred Label : incretin mimetics and incretin enhancers;

Query (CISMeF) : incrétinomimétiques et incrétinopotentialisateurs.ti ou (Inhibiteurs de la dipeptidyl-peptidase IV.mc ou glucagon-like peptide 1/analogues et derives.mc ou (Récepteur du glucagon-like peptide.sc et Récepteurs au glucagon/agonistes.mc) ou exenatide.sc ou liraglutide.sc ou (lixisenatide.co ou lixisenatide.tc) ou sitagliptine.sc ou saxagliptine.sc ou linagliptine.sc ou vildagliptine.sc);

CISMeF synonym : incretin mimetics and enhancers;

PubMed query (by CISMeF) : %22incretin mimetics and incretin enhancers%22[TIAB] OR (%22dipeptidyl-peptidase iv inhibitors%22[MH] OR %22glucagon-like peptide 1/analogs and derivatives%22[MH] OR (%22receptors, glucagon/agonists%22[MH]) OR %22exenatide%22[NM] OR %22liraglutide%22[NM] OR (%22Lixisenatide%22[TIAB] OR %22lixisenatide%22[ALL]) OR %22sitagliptin%22[NM] OR %22saxagliptin%22[NM] OR %22linagliptin%22[NM] OR %22vildagliptin%22[NM])

Details


You can consult :


Nous contacter.
04/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.